Lexicon Pharmaceuticals
LXRX
#7257
Rank
โ‚ฌ0.40 B
Marketcap
1,12ย โ‚ฌ
Share price
0.00%
Change (1 day)
32.75%
Change (1 year)

Revenue for Lexicon Pharmaceuticals (LXRX)

Revenue in 2025 (TTM): โ‚ฌ63.25 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ60.36 Million. In 2024 the company made a revenue of โ‚ฌ29.86 Million an increase over the revenue in the year 2023 that were of โ‚ฌ1.09 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lexicon Pharmaceuticals from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ63.25 M111.79%
2024 โ‚ฌ29.86 M2640.07%
2023 โ‚ฌ1.09 M741.19%
2022 โ‚ฌ0.12 M-50.75%
2021 โ‚ฌ0.26 M-98.65%
2020 โ‚ฌ19.5 M-93.21%
2019 โ‚ฌ0.28 B417.71%
2018 โ‚ฌ55.53 M-26.24%
2017 โ‚ฌ75.28 M-4.97%
2016 โ‚ฌ79.22 M-33.37%
2015 โ‚ฌ0.11 B532.79%
2014 โ‚ฌ18.79 M1067.9%
2013 โ‚ฌ1.6 M95.44%
2012 โ‚ฌ0.82 M-42.18%
2011 โ‚ฌ1.42 M-61.41%
2010 โ‚ฌ3.68 M-50.59%
2009 โ‚ฌ7.46 M-67.7%
2008 โ‚ฌ23.11 M-32.64%
2007 โ‚ฌ34.32 M-37.78%
2006 โ‚ฌ55.17 M-13.64%
2005 โ‚ฌ63.88 M40.37%
2004 โ‚ฌ45.51 M33.77%
2003 โ‚ฌ34.02 M1.05%
2002 โ‚ฌ33.67 M-90.27%
2001 โ‚ฌ0.34 B2154.44%
2000 โ‚ฌ15.34 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ0 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ12.13 B 20,005.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚ฌ0.53 B 789.87%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ2.63 B 4,266.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ37.25 B 61,616.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ0.25 B 328.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ3.65 B 5,951.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.21 B 254.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.18 B 201.90%๐Ÿ‡บ๐Ÿ‡ธ USA